Zeyun Mi

613 total citations
26 papers, 462 citations indexed

About

Zeyun Mi is a scholar working on Molecular Biology, Virology and Infectious Diseases. According to data from OpenAlex, Zeyun Mi has authored 26 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Virology and 9 papers in Infectious Diseases. Recurrent topics in Zeyun Mi's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers) and Renal and related cancers (5 papers). Zeyun Mi is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (9 papers) and Renal and related cancers (5 papers). Zeyun Mi collaborates with scholars based in China, Canada and United States. Zeyun Mi's co-authors include Zhiqiang Wu, Zhiyong Yuan, Maobin Meng, Shan Cen, Lirong Zhang, Zhiheng Liu, Yupeng Chen, Xiaoyu Li, Jinming Zhou and Yi Lu and has published in prestigious journals such as Biochemistry, Cancer Research and Scientific Reports.

In The Last Decade

Zeyun Mi

25 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeyun Mi China 13 295 92 82 60 57 26 462
Bing Hu China 8 183 0.6× 64 0.7× 46 0.6× 70 1.2× 30 0.5× 14 304
Robert Buckland United Kingdom 12 248 0.8× 51 0.6× 54 0.7× 23 0.4× 18 0.3× 19 545
Octavio A. Quiñones United States 13 216 0.7× 53 0.6× 28 0.3× 92 1.5× 37 0.6× 17 498
Michael A. McIlhatton United States 12 548 1.9× 169 1.8× 74 0.9× 35 0.6× 24 0.4× 15 766
Luke O. Dannenberg United States 6 301 1.0× 38 0.4× 68 0.8× 119 2.0× 10 0.2× 6 409
Van Leung‐Pineda United States 11 466 1.6× 60 0.7× 57 0.7× 24 0.4× 25 0.4× 19 785
Shinji Sato Japan 10 184 0.6× 39 0.4× 55 0.7× 15 0.3× 33 0.6× 28 632
Zvi Shalev Israel 12 230 0.8× 69 0.8× 55 0.7× 14 0.2× 19 0.3× 16 491
I. А. Orlovskaya Russia 13 234 0.8× 28 0.3× 47 0.6× 20 0.3× 33 0.6× 42 523

Countries citing papers authored by Zeyun Mi

Since Specialization
Citations

This map shows the geographic impact of Zeyun Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyun Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyun Mi more than expected).

Fields of papers citing papers by Zeyun Mi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeyun Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyun Mi. The network helps show where Zeyun Mi may publish in the future.

Co-authorship network of co-authors of Zeyun Mi

This figure shows the co-authorship network connecting the top 25 collaborators of Zeyun Mi. A scholar is included among the top collaborators of Zeyun Mi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeyun Mi. Zeyun Mi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shi, Jinming, et al.. (2025). CAD hijacks STING to impair antitumor immunity and radiotherapy efficacy of colorectal cancer. Cell Death and Disease. 16(1). 641–641. 1 indexed citations
2.
Yang, Yichen, Lu Chen, Ben Liu, et al.. (2025). CRTC2 Forms Co-Condensates with YTHDF2 That Enhance Translational Efficiency of m6A-Modified mRNAs to Drive Hepatocarcinogenesis and Lenvatinib Resistance. Cancer Research. 85(11). 2046–2066. 2 indexed citations
3.
Wang, Meixi, et al.. (2024). The EGR1/miR-139/NRF2 axis orchestrates radiosensitivity of non-small-cell lung cancer via ferroptosis. Cancer Letters. 595. 217000–217000. 19 indexed citations
4.
Sun, Yanchen, Jing Wang, Maobin Meng, et al.. (2024). MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-κB. Cancer Biology and Medicine. 21(11). 1–17.
6.
Wang, Xin, Zeyun Mi, Xiangli Jiang, et al.. (2021). STAT3/miR-135b/NF-κB axis confers aggressiveness and unfavorable prognosis in non-small-cell lung cancer. Cell Death and Disease. 12(5). 493–493. 45 indexed citations
7.
Lu, Yi, Zhiheng Liu, Xu Zhu, et al.. (2020). Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease. Science Translational Medicine. 12(554). 85 indexed citations
8.
Mi, Zeyun, Xinyi Cao, Yi Lu, et al.. (2020). Super-enhancer-driven metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease. Nature Metabolism. 2(8). 717–731. 24 indexed citations
9.
Liu, Zhiheng, Xinyi Cao, Yi Lu, et al.. (2019). Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease. Science Advances. 5(6). eaaw3593–eaaw3593. 34 indexed citations
10.
Wu, Zhiqiang, Yu Guo, Zhuang Liu, et al.. (2019). OTU deubiquitinase 4 is silenced and radiosensitizes non-small cell lung cancer cells via inhibiting DNA repair. Cancer Cell International. 19(1). 99–99. 24 indexed citations
11.
Wu, Zhiqiang, Zhuang Liu, Xiangli Jiang, et al.. (2019). Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits. Journal of Experimental & Clinical Cancer Research. 38(1). 341–341. 19 indexed citations
12.
Ding, Jiwei, Jianyuan Zhao, Zhijun Yang, et al.. (2017). Microbial Natural Product Alternariol 5-O-Methyl Ether Inhibits HIV-1 Integration by Blocking Nuclear Import of the Pre-Integration Complex. Viruses. 9(5). 105–105. 17 indexed citations
13.
Zhang, Quan, Zeyun Mi, Yuming Huang, et al.. (2016). 2-thio-6-azauridine inhibits Vpu mediated BST-2 degradation. Retrovirology. 13(1). 13–13. 12 indexed citations
14.
Ding, Jiwei, et al.. (2016). [The sensitivity of transmitted/founder HIV-1 to anti-HIV drugs].. PubMed. 51(3). 367–72. 1 indexed citations
15.
Ding, Jiwei, et al.. (2016). Citron kinase enhances ubiquitination of HIV-1 Gag protein and intracellular HIV-1 budding. Archives of Virology. 161(9). 2441–2448. 12 indexed citations
16.
Mi, Zeyun, Jiwei Ding, Quan Zhang, et al.. (2015). A small molecule compound IMB-LA inhibits HIV-1 infection by preventing viral Vpu from antagonizing the host restriction factor BST-2. Scientific Reports. 5(1). 18499–18499. 17 indexed citations
17.
Wang, Xin, Xiaoyu Li, Jing Ma, et al.. (2014). Human APOBEC3F incorporation into human immunodeficiency virus type 1 particles. Virus Research. 191. 30–38. 8 indexed citations
18.
Yang, Aimin, et al.. (2011). Central administration of neuronostatin induces antinociception in mice. Peptides. 32(9). 1893–1901. 11 indexed citations
19.
Yang, Aimin, et al.. (2011). Intracerebroventricular administration of neuronostatin induces depression-like effect in forced swim test of mice. Peptides. 32(9). 1948–1952. 12 indexed citations
20.
Zhang, Quan, Zhenlong Liu, Zeyun Mi, et al.. (2011). High-throughput assay to identify inhibitors of Vpu-mediated down-regulation of cell surface BST-2. Antiviral Research. 91(3). 321–329. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026